March 1, 2013
March is Save your Vision Month and in keeping with this month’s theme we are proud to announce an exciting new clinical research trial that is being offered by Dr. Steve Khachikian at Black Hills Regional Eye Institute in Rapid City, SD.
This new trial is for patients with Keratoconus or Corneal Ectasia after refractive surgery (LASIK). The trial will be studying the benefits of Corneal Collagen Crosslinking for these ocular conditions. Corneal Collagen Crosslinking has shown tremendous promise in slowing or possibly even stopping the progression of Keratoconus and Corneal Ectasia.
The study will be conducted over a 12 month period and will require approximately 8 trips to Dr. Khachikian’s office in Rapid City for the one-time treatment and then subsequent follow-up visits. Participation is voluntary, but all participants will receive treatment, no patients will receive placebos.
To participate in the study patients must be at least 12 years of age and have Keratoconus or Corneal Ectasia. Several other qualifications must be met and Dr. Hoff and Dr. King can help you determine if you may be eligible to participate in this exciting and beneficial new research and provide you with more information.
If you or a loved one suffer from Keratoconus or have developed Corneal Ectasia after LASIK please call our office for more information today. This is an exciting opportunity for patients in our area and we hope many of our patients, current and future, will be able to benefit from this research.
Dr. Candace Hoff